StephenJSmithMD

PubMed

• A Multi-Institutional Outcomes Analysis of Patients with Relapsed or Refractory DLBCL Treated with Ibrutinib
  Stephen Smith, Daniel J. Landsburg, Paolo Caimi, Mazyar Shadman> ;Blood.
• 6 citations
  Phase II study of the Multikinase inhibitor of angiogenesis, Linifanib, in patients with metastatic and refractory colorectal cancer expressing mutated KRAS
  Emily Chan, Laura W. Goff, Dana Backlund Cardin, Kristin K. Ancell, Stephen James Smith, Jennifer G. Whisenant, Jordan Berlin> ;Investigational New Drugs. 2017 Mar 28
• 6 citations
  A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers
  Laura W. Goff, Dana Backlund Cardin, Jennifer G. Whisenant, Liping Du, Tatsuki Koyama, Kimberly B. Dahlman, Safia N. Salaria, Ruth T. Young, Kristen K. Ciombor, Jill G...> ;Investigational New Drugs. 2017 Feb 1
• 41 citations
  LIM Domain Only-2 (LMO2) induces T-cell leukemia by two distinct pathways
  Stephen B. Smith, Rati Tripathi, Charnise Goodings, Susan M. Cleveland, Elizabeth Mathias, J. Andrew Hardaway, Natalina Elliott, Yajun Yi, Xi Chen, James R. Downing, C...> ;Plos One. 2014 Jan 21
• Amplification of the RARA gene in acute myeloid leukemia: significant finding or coincidental observation?
  Asleson AD Morgan V Smith S Velagaleti GV> ;Cancer Genet Cytogenet. 2010 Oct 1
• Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer.
  Fleming RA Capizzi RL Muss HB Smith S Fernandes DJ Homesley H Loggie BW Case L Morris R Russell GB Richards F> ;Clin Cancer Res. 1996 Jul
• Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B study.
  Fleming RA Capizzi RL Rosner GL Oliver LK Smith SJ Schiffer CA Silver RT Peterson BA Weiss RB Omura GA et al.> ;Cancer Chemother Pharmacol. 1995
• Join now to see all